基于扩散峰度成像术前识别肝细胞癌CK19表达状态
本研究为前瞻性单中心研究,纳入73例病理确诊的肝细胞癌患者,采用3.0T MR扫描仪行扩散峰度成像(DKI)及扩散加权成像(DWI),比较CK19阳性与阴性组的MD、MK、ADC及信号强度比。多因素分析显示MD值降低和AFP升高是CK19阳性的独立危险因素,MD值预测CK19阳性的AUC为0.823,敏感度86.96%,特异度76%。
要点
- DKI衍生的MD值降低与肝细胞癌CK19阳性表达独立相关。
- MD值预测CK19阳性AUC为0.823,敏感度86.96%,特异度76%。
- AFP升高亦是CK19阳性的独立危险因素(OR=5.139)。
关键影像表现/征象
- CK19阳性组MD值较阴性组降低(p<0.001)。
- CK19阳性组ADC值较阴性组降低(p=0.021)。
- CK19阳性组SIRb500较阴性组升高(p=0.006)。
- CK19阳性组甲胎蛋白水平较阴性组升高(p=0.021)。
诊断标准与关键数值
- MD值预测CK19阳性肝细胞癌的AUC为0.823,敏感度86.96%,特异度76%。
- 多因素分析中MD值降低的OR为0.042(p=0.002),AFP升高的OR为5.139(p=0.015)。
临床应用与阅片要点
- 阅片时可关注DKI-derived MD值,MD值降低提示CK19阳性可能,需结合AFP等临床信息综合判断。
- ADC值降低和SIRb500升高亦与CK19阳性相关,可作为辅助参考。
局限性
- 单中心前瞻性研究,样本量有限(73例),结论需多中心验证。
- 未报告DKI参数的可重复性及观察者间一致性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To explore the potential value of diffusion kurtosis imaging (DKI) for identification of cytokeratin 19 (CK19) status of HCCs.
METHODS: This study was approved by the local institute review board and written informed consent was obtained. 73 patients with pathologically confirmed HCCs were included in this prospective study. All the diffusion-weighted (DW) images were acquired using a 3.0-T MR scanner with 4 b-values (0, 800, 1500 and 2000 s/mm2). The mean diffusion value (MD) and mean kurtosis coefficient (MK) from DKI, apparent diffusion coefficient (ADC) from DW imaging (b = 0, 500 s/mm2), and tumor-to-liver signal intensity ratios on ADC map (SIRADC) and DW images with b-value of 500 s/mm2 (SIRb500) were calculated and compared between CK19-positive (n = 23) and CK19-negative (n = 50) HCC groups. Univariate and multivariate logistic regression analyses were used to identify risk factors for the positive expression of CK19.
RESULTS: Increased a-fetoprotein level (p = 0.021) and SIRb500 (p = 0.006) and decreased ADC (p = 0.021) and MD (p < 0.001) were significantly correlated with CK19-positive HCCs at univariate analysis. Decreased MD value (odds ratio: 0.042, p = 0.002) and a-fetoprotein level (odds ratio: 5.139, p = 0.015) were the independent risk factors for CK19-positive HCCs at multivariate analysis. The area under the curve of MD value by receiver operating characteristic analysis was 0.823 with a sensitivity of 86.96% and a specificity of 76% for the prediction of CK19-positive HCCs.
CONCLUSION: The decreased MD value derived from DKI is potential quantitative biomarker for predicting CK19-positive HCCs.
引用
- Chen, Liu, Guo, et al. Preoperative identification of cytokeratin 19 status of hepatocellular carcinoma based on diffusion kurtosis imaging. Abdom Radiol (NY). 2022. PMID: 36416905. doi:10.1007/s00261-022-03736-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。